title: Dexmedetomidine infusion for sedation in the intensive care setting in an infant with airway compromise due to congenital mediastinal neuroblastoma.
authors.forename: Mitsutaka
authors.initials: M
authors.lastname: Shiota
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Oda
authors.forename: Masashi
authors.initials: M
authors.lastname: Taniguchi
authors.forename: Takayuki
authors.initials: T
authors.lastname: Hamabata
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mizumoto
authors.forename: Daisuke
authors.initials: D
authors.lastname: Hata
mesh_terms: D058109:Airway Management / Q000379:methods*; D000402:Airway Obstruction / Q000209:etiology / Q000628:therapy*; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016190:Carboplatin / Q000627:therapeutic use; D003422:Critical Care; D020927:Dexmedetomidine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005283:Fentanyl / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008479:Mediastinal Neoplasms / Q000150:complications* / Q000151:congenital / Q000188:drug therapy; D008874:Midazolam / Q000009:adverse effects / Q000627:therapeutic use; D009447:Neuroblastoma / Q000150:complications / Q000151:congenital / Q000188:drug therapy
chemical_list: D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine; D016190:Carboplatin; D008874:Midazolam; D005283:Fentanyl